SM Research supports complex clinical development across high‑impact therapeutic areas. Our teams combine operational expertise with medical and scientific insight to accelerate enrollment and deliver inspection‑ready data.
Solid tumors, hematology, immuno‑oncology, biomarker‑driven designs, complex eligibility and adaptive designs.
Depression, anxiety, psychosis, neurodevelopmental disorders; in‑house psychiatric nursing, rater training and scale fidelity.
Neurodegeneration, movement disorders, epilepsy; imaging‑heavy protocols, complex endpoints, caregiver pathways.
Type 1/2, metabolic disorders; device integrations, PRO/ePRO, real‑world endpoints and long‑term safety follow‑up.
Heart failure, atherosclerosis, hypertension; risk‑based monitoring and complex safety profiles.
Antivirals, antibacterials, vaccines; high‑throughput sites, cold‑chain coordination, and safety oversight.
Orphan indications, small cohorts, natural history designs, site enablement and patient advocacy engagement.
ISO 14155; usability, HF/E, pre‑ and post‑market clinical investigations and registry builds.
IVD and companion diagnostics; analytical/clinical validation, CDx alignment with therapeutic development.